Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Long-Term Investments (2016 - 2018)

Utah Medical Products has reported Long-Term Investments over the past 7 years, most recently at $72000.0 for Q1 2018.

  • Quarterly results put Long-Term Investments at $72000.0 for Q1 2018, up 12.5% from a year ago — trailing twelve months through Mar 2018 was $72000.0 (up 12.5% YoY), and the annual figure for FY2017 was $80000.0, up 25.0%.
  • Long-Term Investments for Q1 2018 was $72000.0 at Utah Medical Products, down from $80000.0 in the prior quarter.
  • Over the last five years, Long-Term Investments for UTMD hit a ceiling of $80000.0 in Q4 2017 and a floor of $44000.0 in Q1 2016.
  • Median Long-Term Investments over the past 5 years was $56000.0 (2014), compared with a mean of $59294.1.
  • Biggest five-year swings in Long-Term Investments: dropped 23.73% in 2016 and later skyrocketed 60.0% in 2017.
  • Utah Medical Products' Long-Term Investments stood at $58000.0 in 2014, then fell by 5.17% to $55000.0 in 2015, then increased by 16.36% to $64000.0 in 2016, then increased by 25.0% to $80000.0 in 2017, then dropped by 10.0% to $72000.0 in 2018.
  • The last three reported values for Long-Term Investments were $72000.0 (Q1 2018), $80000.0 (Q4 2017), and $78000.0 (Q3 2017) per Business Quant data.